Executive conferences are no longer about collecting slides. They are about exchanging ideas, challenging assumptions, and building relationships that shape better commercial decisions. Discover why we look forward to meeting leaders in New York.

Pricing pressure is not the root problem. It is exposing weaknesses in Pricing Governance, gross-to-net transparency, and commercial operating models. Discover why leading pharmaceutical organizations are responding through Commercial Transformation.

Ahead of Fernando Ventureira's Closing Keynote at the B2B Pricing & Commercial Excellence Summit America 2026, we explore why sustainable competitive advantage depends more on integrated decision-making than on isolated pricing initiatives.

Aleksandar Ruzicic has been appointed Senior Vice President and Advisory Expert Member at Stratence Partners, strengthening pharma and healthcare transformation expertise.

Commercial Transformation delivers sustainable competitive advantage when strategy, pricing economics, governance, data intelligence, and execution operate as one integrated system.

Eduardo Kühnel has been appointed Senior Vice President, Head of Alliances and Ecosystem, and Advisory Board Member at Stratence Partners, reinforcing global ecosystem development and international growth capabilities.

After two days of discussions with pricing, commercial, and transformation leaders in Frankfurt, Fernando Ventureira shares three key observations shaping the future of Commercial Transformation.

Industrial organizations are facing growing pressure from fragmented pricing governance, operational complexity, and disconnected commercial execution. This article explores why Commercial Transformation is becoming a structural operating discipline across industrial sectors.

Stratence Partners appoints Greg Varner as Senior Vice President North America and Advisory Board Member, reinforcing international Commercial Transformation capabilities across strategy, pricing and operational excellence.

Commercial complexity in Animal Health is accelerating across pricing, distribution, commercial governance, and execution models. In this executive perspective, Stratence Partners explores why Commercial Transformation is becoming a structural capability for organizations seeking sustainable profitability and disciplined growth.

Medical Devices organizations are facing growing margin pressure not because pricing teams are failing, but because commercial governance structures are increasingly fragmented. Stratence Partners explores why Commercial Transformation has become a structural operating necessity.

Stratence Partners announces the appointment of David Diaz as Senior Vice President Iberia & LATAM and Advisory Board Member, reinforcing its international executive leadership expansion.

Utilities organizations increasingly face execution complexity, fragmented pricing governance, and margin leakage hidden inside disconnected commercial systems. Discover how SPIE+AI™ structures commercial control into one governed operating framework.

Fernando Ventureira closed the B2B Pricing & Commercial Excellence Summit Europe 2026 with a keynote focused on Commercial Transformation, execution discipline, pricing governance, and sustainable competitive advantage.

Utilities companies are facing structural margin erosion not due to strategy failure, but execution gaps. Discover how Commercial Transformation restores control.

Oil & Gas margin erosion is no longer driven by market volatility alone, but by fragmented commercial execution. This article explains why Commercial Transformation is now critical.

Fernando Ventureira will speak at the B2B Pricing & Commercial Excellence Summit Europe 2026, addressing how organizations connect strategy, pricing, and execution to drive sustainable commercial performance.

Most companies define strong strategies but struggle to execute them consistently. The gap lies in fragmented pricing, data, and decision systems. This article explains how leading organizations build a sustainable competitive edge through integrated commercial transformation.

Chemical companies are losing control over pricing and margins. Discover how Commercial Transformation restores visibility, governance, and execution discipline.

Pharma is not facing a pricing problem, but a fragmented commercial system. Discover why CEOs must now lead Commercial Transformation as an integrated operating model.